FAVIPIRAVIR AND DEXAMETHASONE IN MANAGEMENT OF SARS-COV2 INFECTION
Background. The clinical presentation of Coronavirus disease 19 (COVID-19) varies from mild symptoms to severe illness including multiorgan dysfunction. Favipiravir is an antiviral agent which has been previously used for treatment of influenza and was recently approved for treatment of mild to mode...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ukrmedknyha
2021-05-01
|
| Series: | International Journal of Medicine and Medical Research |
| Subjects: | |
| Online Access: | https://ojs.tdmu.edu.ua/index.php/ijmr/article/view/11485 |